Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimo Dietrich

Showing results (31-40 of 116) with videos related to

Pageof 12
Sort By:
Oncoimmunology|September 18, 2018
Detailed analysis of adenosine A2a receptor (Timo J Vogt, Heidrun Gevensleben, Jörn Dietrich, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 23, 2011
SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer in plasmaChristoph Kneip, Bernd Schmidt, Anke Seegebarth, et al.
Plos One|February 10, 2018
Intragenic DNA methylation of PITX1 and the adjacent long non-coding RNA C5orf66-AS1 are prognostic biomarkers in patients with head and neck squamous cell carcinomasVerena Sailer, Arthur Charpentier, Joern Dietrich, et al.
Melanoma Research|February 3, 2023
DNA methylation of GITR, OX40, 4-1BB, CD27 , and CD40 correlates with BAP1 aberrancy and prognosis in uveal melanomaFriederike Hoffmann, Anne Fröhlich, Judith Sirokay, et al.
JCI Insight|July 13, 2018
CTLA4 methylation predicts response to anti-PD-1 and anti-CTLA-4 immunotherapy in melanoma patientsDiane Goltz, Heidrun Gevensleben, Timo J Vogt, et al.
Virchows Archiv : an International Journal of Pathology|November 23, 2015
TRPM4 protein expression in prostate cancer: a novel tissue biomarker associated with risk of biochemical recurrence following radical prostatectomyKasper Drimer Berg, Davide Soldini, Maria Jung, et al.
Epigenomics|March 2, 2019
Clinicopathological, immune and molecular correlates of <i>PD-L2</i> methylation in gastric adenocarcinomasPhilipp Lingohr, Jonas Dohmen, Alexander Semaan, et al.
Epigenomics|December 22, 2020
The DNA methylation landscape of <i>PD-1</i> (<i>PDCD1</i>) and adjacent lncRNA <i>AC131097.3</i> in head and neck squamous cell carcinomaChristopher Bockhorst, Jörn Dietrich, Timo J Vogt, et al.
Plos One|January 4, 2014
Diagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant and malignant pleural effusionsDimo Dietrich, Maria Jung, Svenja Puetzer, et al.
Translational Oncology|July 4, 2017
Systematic Analysis of the Expression of the Mitochondrial ATP Synthase (Complex V) Subunits in Clear Cell Renal Cell CarcinomaMaria Brüggemann, Arabella Gromes, Mirjam Poss, et al.
Pageof 12

Showing results (31-40 of 116) with videos related to

Sort By:
Pageof 12
Oncoimmunology|September 18, 2018
Detailed analysis of adenosine A2a receptor (Timo J Vogt, Heidrun Gevensleben, Jörn Dietrich, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 23, 2011
SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer in plasmaChristoph Kneip, Bernd Schmidt, Anke Seegebarth, et al.
Plos One|February 10, 2018
Intragenic DNA methylation of PITX1 and the adjacent long non-coding RNA C5orf66-AS1 are prognostic biomarkers in patients with head and neck squamous cell carcinomasVerena Sailer, Arthur Charpentier, Joern Dietrich, et al.
Melanoma Research|February 3, 2023
DNA methylation of GITR, OX40, 4-1BB, CD27 , and CD40 correlates with BAP1 aberrancy and prognosis in uveal melanomaFriederike Hoffmann, Anne Fröhlich, Judith Sirokay, et al.
JCI Insight|July 13, 2018
CTLA4 methylation predicts response to anti-PD-1 and anti-CTLA-4 immunotherapy in melanoma patientsDiane Goltz, Heidrun Gevensleben, Timo J Vogt, et al.
Virchows Archiv : an International Journal of Pathology|November 23, 2015
TRPM4 protein expression in prostate cancer: a novel tissue biomarker associated with risk of biochemical recurrence following radical prostatectomyKasper Drimer Berg, Davide Soldini, Maria Jung, et al.
Epigenomics|March 2, 2019
Clinicopathological, immune and molecular correlates of <i>PD-L2</i> methylation in gastric adenocarcinomasPhilipp Lingohr, Jonas Dohmen, Alexander Semaan, et al.
Epigenomics|December 22, 2020
The DNA methylation landscape of <i>PD-1</i> (<i>PDCD1</i>) and adjacent lncRNA <i>AC131097.3</i> in head and neck squamous cell carcinomaChristopher Bockhorst, Jörn Dietrich, Timo J Vogt, et al.
Plos One|January 4, 2014
Diagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant and malignant pleural effusionsDimo Dietrich, Maria Jung, Svenja Puetzer, et al.
Translational Oncology|July 4, 2017
Systematic Analysis of the Expression of the Mitochondrial ATP Synthase (Complex V) Subunits in Clear Cell Renal Cell CarcinomaMaria Brüggemann, Arabella Gromes, Mirjam Poss, et al.
Pageof 12